SEC Filing Details

Document Details

Form
Filing Date
Jul 20, 2022
Document Date
Jul 14, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Sensei Biotherapeutics, Inc
Issuer
SENSEI BIOTHERAPEUTICS, INC.
Filer
APEIRON INVESTMENT GROUP LTD.

HQ: 451 D St, Unit 710 , Boston, MA 02210

MD: 1405 Research Blvd, Suite 125,
Rockville, MD 20850